Hubermans statement on differences between indica and sativa strains is based in part on the following PubMed referenced sources which include subjective experiences of users, reads the statement from Hubermans rep, with links to two research articles
Similarly, at Turku Bioscience, M
What the Clinical Evidence Honestly Does Not Yet Show Intellectual honesty requires stating plainly what the research base does not support: No randomised controlled trial exists for the KLOW stack as a combined formulation
These multisystem benefits create a healthcare ROI calculation where GLP-1 therapy prevents conditions with substantially higher lifetime treatment costs than the drug itself
OVERVIEW OF THE DSNP LANDSCAPE The DSNP landscape can be viewed from a variety of perspectives, including the number of dual eligible beneficiaries these plans enroll, their service areas, and the degree of Medicare-Medicaid integration required in the contracts that they have with states